Paper Review Records
全部论文审稿周期
11 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
82
天
Natural dehydrocostus lactone-based analogues as new structural PDPK1 allosteric activators against HBV
作者
Hang Sun; Yu-Jing Mao; Dan-Yang Zhu; Rui-Xian Xu; Bi-Cheng Zhang; Ying Sang; Yi-Zhi Liu; Yang Feng; Guotai Yang; Hao Chen; Shao-Xing Dai; Min Xu展开收起
作者单位
Yunnan Key Laboratory of Cross-Border Infectious Disease Control and Prevention and Novel Drug Development (Under Construction), Center for Pharmaceutical Sciences, Faculty of Life Science and Technology, Kunming University of Science and Technology, Chenggong Campus, Kunming, 650500, China; State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, 650500, China展开收起
75
天
Exploring the role of conformational restriction in 5-alkyl-6-benzyl-2-{[(methylthio)methyl]thio}pyrimidin-4(3H)-ones: Effects in HIV-1 infected cells and reverse transcriptase enzymes
作者
Egor Degtyarenko; Gebremedhin Solomon Hailu; Emanuele Fabbrizi; Anastasia Golovina; Andrey Voronkov; Roberta Astolfi; Lidia Giuliani; Andrea Mancini; Maxim B. Nawrozkij; Vladimir Chernyshov; Clarissa Pupillo; Roberto Cirilli; Laura Bavagnoli; Rino Ragno; José A. Esté; Emmanuele Crespan; Francesco Fiorentino; Roman Ivanov; Antonello Mai; Dante Rotili展开收起
作者单位
Institute of Physiologically Active Compounds, Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Moscow Region, 142432, Russia; Department of Science, Roma Tre University, Rome, 00146, Italy; Department of Drug Chemistry and Technologies, Sapienza University of Rome, Rome, 00185, Italy; Medicinal Biotechnology Department, Sirius University of Science and Technology, Olimpiyskiy Ave. 1, Sirius, Krasnodar Region, 354340, Russia; Institute of Biophysics of the Future, Institutsky lane, 9, Building 7, Dolgoprudny, Moscow region, 141701, Russia; Department of Chemistry, Sapienza University of Rome, Pale Aldo Moro 5, Rome, Italy; Centro Nazionale per il Controllo e la Valutazione dei Farmaci, Istituto Superiore di Sanità, Viale Regina Elena 299, Roma, 00161, Italy; Istituto di Genetica Molecolare IGM-CNR, via Abbiategrasso 207, Pavia, 27100, Italy; Universitat Internacional de Catalunya, C/ Josep Trueta s/n., Barcelona, 08195, Spain; Department of Biochemical Sciences, Sapienza University of Rome, Rome, 00185, Italy; Biostructures and Biosystems National Institute (INBB), Rome, 00165, Italy展开收起
99
天
Targeting the myeloid immune checkpoint ILT3 (LILRB4) with small molecules enables reprogramming of suppressive tumor immunity
作者
Somaya A. Abdel-Rahman; Antonio Monari; Tom Miclot; Florent Barbault; Moustafa T. Gabr展开收起
作者单位
Department of Radiology, Columbia University Irving Medical Center, New York, NY, 10032, USA; Department of Radiology, Weill Cornell Medicine, New York, NY, 10065, USA; Université Paris Cité, CNRS, ITODYS, Paris, F-75013, France展开收起
30
天
Discovery of a highly selective FLT3-ITD inhibitor with potent antileukemic activity based on 4-(2-fluorophenoxy)pyridine scaffold
作者
Zhongyuan Wang; Yiwei Zhang; Lin Li; Yunfeng Wang; Dan Yang; Qingmei Song; Qingqing Fu; Dongsheng Zhao; Lei Tang; Weiwei Ouyang; Yue'e Chai; Weike Liao展开收起
作者单位
Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, 550002, China; State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang, 550004, China; Department of Oncology, Affiliated Hospital of Guizhou Medical University and Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, 550001, China; Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, 103 Wenhua Road, Shenhe District, Shenyang, 110016, China展开收起
40
天
Discovery and characterization of PGC-01: An effective GSDMD-targeting PROTAC
作者
Qian-qian Wang; Rong-ying Hou; Yi-xuan Shua; Ya-fei Xu; Wen-jing Bian; Wen Xiao; Yu-qing Chen; Bing-yu Zhou; Yue Gao; Li Liu; Yu-hang Wang; Yi-bei Xiao; Cheng Jiang展开收起
作者单位
School of Pharmacy, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, 211198, China; Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China; State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China; Center of Drug Metabolism and Pharmacokinetics, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China展开收起
175
天
In silico identification and biological evaluation of newly synthetic hinokiflavone derivatives as multi-kinase inhibitors with preferential Aurora A activity for ovarian cancer therapy
作者
Ke Wang; Guan-Yu Chen; Pei‐Yi Chu; Yi-Cheng Pan; Wei-Yu Hsu; Yun-Hao Dai; Yu-Liang Yang; Yeong-Jiunn Jang; Yang-Chang Wu展开收起
作者单位
School of Pharmaceutical Sciences, Jiangsu Provincial University Key Laboratory of Green Biomanufacturing for Pharmaceuticals, Nanjing Tech University, Nanjing, 211816, China; Chinese Medicine Research and Development Center, China Medical University Hospital, Taichung, 404327, Taiwan; Master Program of Pharmaceutical Manufacture, College of Pharmacy, China Medical University, Taichung, Taiwan; Agricultural Biotechnology Research Center, Academia Sinica, Taipei, 11529, Taiwan; Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung, 404333, Taiwan; Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung, Taiwan展开收起
FAQ
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY审稿要多久?
截至2026-11-19,CrushSCI 收录了 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 的 11 篇完整审稿记录。最快一篇从收稿到录用用了 30 天(Discovery of a highly selective FLT3-ITD inhibitor with potent antileukemic activity based on 4-(2-fluorophenoxy)pyridine scaffold,2026-07-28 收稿,2026-08-27 录用),最慢一篇用了 175 天;平均 78.1 天,中位数 60 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
